Finance

BioXcel Therapeutics, a pioneering biopharmaceutical entity leveraging artificial intelligence in the pursuit of revolutionary advancements in neuroscience medicine, announced today that the Centers for Medicare

Conduit Pharmaceuticals, the biopharmaceutical entity, witnessed an unexpected surge in its stock value on Monday, defying the absence of any noteworthy developments or announcements from

In a major stride forward for Reviva Pharmaceuticals Holdings, the company’s stock has witnessed a significant surge subsequent to the release of promising topline results

In a historic development, the United Auto Workers (UAW) union and General Motors have come to a tentative agreement, marking the conclusion of the first-ever

In a strategic move to restructure its common stock, clinical stage biopharmaceutical company PaxMedica announced today the successful execution of a 1-for-17 reverse stock split.